Obat baru :Firazyr (icatibant) sebagai antiangioedema herediter

Australian Public Assessment Report for Icatibanticatibant

firazyr, icatibant, antiangioedema herediter

FDA baru saja merelease obat baru antiangiodema herediter yaitu Firazyr (icatibant). Sediaan injeksi ini diindikasikan untuk gangguan angioedema herediter. Angioedema herediter termasuk gangguan pembuluh darah yang jarang terjadi tetapi berbahaya. Dengan adanya obat baru ini maka akibat fatal akibat gangguan angioedema herediter dapat diperkecil.

Obat baru ini telah direlease oleh FDA pada tanggal 25 -08-2011. Baca selengkapnya release FDA pada sbb:

FDA NEWS RELEASE

For Immediate Release: August 25, 2011
Media Inquiries: Morgan Liscinsky, 301-796-0397, morgan.liscinsky@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

FDA approves Firazyr to treat acute attacks of hereditary angioedema

The U.S. Food and Drug Administration today approved Firazyr (icatibant) Injection for the treatment of acute attacks of a rare condition called hereditary angioedema (HAE) in people ages 18 years and older.

HAE is caused by low levels or the improper function of a protein called C1 inhibitor, which is involved in regulating how certain immune system and blood clotting pathways function. There is usually a family history of the condition. Fewer than 30,000 people in the United States have HAE.

People with HAE can develop rapid swelling of the hands, feet, limbs, face, intestinal tract, voice box, or windpipe, which may result in disfigurement, disability, or death. Swelling of the digestive tract may cause abdominal pain, nausea, and vomiting, while airway swelling puts patients at risk of suffocation.

“Firazyr provides a new option to treat acute attacks of HAE and because it can be self-administered through an injection in the abdominal area, patients can treat themselves upon recognition of an HAE attack,” said Curtis Rosebraugh, M.D., M.P.H., director of the Office of Drug Evaluation II in the FDA’s Center for Drug Evaluation and Research.

The safety and efficacy of Firazyr was demonstrated in three controlled clinical trials, with open-label extension periods, in which 225 patients received 1,076 doses of 30 mg Firazyr. The median time for patients treated with Firazyr to report onset of symptom relief was two hours compared with almost 20 hours with placebo.

Firazyr is the third drug approved in the United States to treat HAE attacks. In October 2009 the FDA approved Berinert to treat facial and abdominal attacks of HAE, and Kalbitor was approved in December 2009 to treat acute attacks of HAE in patients ages 16 years and older.

The FDA approved Firazyr with patient counseling information that includes injection instructions. The most common side effects reported by those using Firazyr were injection site reactions, fever, increased liver enzymes, dizziness, and rash.

Firazyr is marketed by Shire Human Genetic Therapies Inc. of Cambridge, Mass.

For more information:

Approved Drugs: Questions and Answers

This entry was posted in Obat Baru on by .

About Webmaster

"My characteristics are:A foundation, order, service, struggle against limits, steady growth. My destiny is to express wonderful organization skills with my ever practical, down-to-earth approach. I’m the kind of person who is always willing to work those long, hard hours to push a project through to completion. My abilities to write and teach may lean toward the more technical and detailed. The positive attitudes; I am one who no doubt, fulfills obligations, and is highly systematic and orderly. I am serious and sincere, honest and faithful. It is my role to help and I am required to do a good job at everything undertake. I may express some of the negative attitudes. The obligations that my face may tend to create frustration and feelings of limitation or restriction. I may sometimes find myself nursing negative attitudes in this regard and these can keep me in a rather low mood. Avoid becoming too rigid, stubborn, dogmatic, and fixed in my opinions. I may have a tendency to develop and hold very strong likes and dislikes, and some of these may border on the classification of prejudice. The negative often produces dominant and bossy individuals who use disciplinarian to an excess. These tendencies must be avoided, hufz..I wish . Finally, I must keep my eye on the big picture and not get overly wrapped up in detail and routine. My desire in life is personal expression, and generally enjoying life to its fullest. I want to participate in an active social life and enjoy a large circle of friends. I want to be in the limelight, expressing my artistic or intellectual talents. Word skills may be my thing; speaking, writing, acting. In a positive sense is friendly, outgoing and always very social. I have a decidedly upbeat attitude that is rarely discouraged; a good mental and emotional balance. My Soul Urge gives intuitive insight, thus, very high creative and inspirational tendencies. The truly outstanding trait shown is that of self-expression, regardless of the field of endeavor. On the negative side, I may at times become too easygoing and too optimistic, tending to scatter forces and accomplish very little. Often, the excessive 3 energy produces non-stop talkers. Everyone has faults, but my urge doesn't appreciate having these pointed out. I dream of being a leader and one who is in charge. I want to be known for my courage, daring, and original ideas. I seek unconquered heights. People may get a first impression that I am very aggressive and sure of myself.

Leave a Reply

Your email address will not be published. Required fields are marked *